Flow Cytometry
- Institution
- SLOAN-KETTERING INST CAN RESEARCH, NY
- Principal investigator
- Rui Gardner
- Funding
- $614K
- Duration
- 1997–2026
Moonbase score
Still being scored
Abstract
ABSTRACT The Flow Cytometry (FC) Core offers centralized expertise and instrumentation in Flow Cytometry and Cell Sorting to investigators of the Cancer Center. The extensive user support includes a) assisting in planning, executing, and analyzing Flow Cytometry experiments; b) daily instrument setup, maintenance, quality control and performance monitoring; c) facilitating instrument access through implementation of adequate polices with an easy and reliable scheduling system; d) offering several software site licenses for high-end Flow data analysis; and e) extensive training and education options. Instrument based-services include operator-assisted cell sorting in five multiparametric FACSAria high-speed cell sorters, useroperated cell sorting in two multiparametric FACSAria cell sorters, and user-operated analysis in five high-end multiparametric analyzers (two LSRII and three LSR Fortessa) and a four-parameter FACSCalibur. Altogether, the availability of high-end instrumentation and highly qualified staff with experience provide investigators of the Center access to highly purified cell populations, and the possibility to characterize cell subsets involved in the processes of tumor development, which can ultimately lead to improved cancer diagnosis and therapy.
LOADING MOONBASE SCORE
Questions for SLOAN-KETTERING INST CAN RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Sloan-Kettering Inst Can Research60
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · $80K · 2025
- NIH · Sloan-Kettering Inst Can Research51
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
Ping Chi · $576K · 2022–2026
- NIH · Sloan-Kettering Inst Can Research49
Targeting stem-like cells and their niche in pancreatic cancer
Tuomas Tammela · $491K · 2025–2026